Business Services Industry
Esperion Co-Founder Dr. Jan Johansson Joins Resverlogix as Senior Vice President of Clinical Affairs.
Canadian Corporate News, March, 2004
CALGARY, ALBERTA, Mar 25, 2004 (CCNMatthews via COMTEX)
Resverlogix Corp. (TSX-V:RVX) today announced the appointment of Jan O. Johansson, M.D., Ph.D., as Senior Vice President of Clinical Affairs.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
"I'm fascinated by the opportunities provided by Resverlogix technologies in the area of identifying novel compounds and the treatment of atherosclerosis, by affecting HDL and reverse cholesterol transport", commented Dr. Johansson. "It is recognized that therapies affecting HDL and atherosclerosis in the arterial wall will present the new opportunity in the $50 billion ...
Read the rest of this article with a Free Trial at HighBeam Research.